Martin Puschmann

Title: Martin Puschmann: Innovator in Gamma Globulin Preparation

Introduction

Martin Puschmann is a notable inventor based in Bergisch Gladbach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of gamma globulin for intravenous administration. His innovative approach has the potential to enhance the efficacy and safety of gamma globulin treatments.

Latest Patents

Puschmann holds a patent for a process titled "Process for preparing gamma globulin suitable for intravenous." This improved method involves dissolving gamma globulin precipitated from blood or blood products in a solution. The process includes separating non-dissolved precipitate from the solution, adding polyethylene glycol, and further refining the gamma globulin for intravenous use. The patent emphasizes the importance of maintaining a neutral pH and specific concentrations of polyethylene glycol during the preparation process.

Career Highlights

Martin Puschmann is associated with Armour Pharma GmbH, where he applies his expertise in pharmaceutical innovations. His work focuses on improving the preparation processes of critical medical products, contributing to advancements in patient care.

Collaborations

Puschmann collaborates with esteemed colleagues, including Jurgen-Dietrich Friedrich-Fiechtl and Bernhard Kerner. Their combined efforts in research and development have fostered a collaborative environment that drives innovation in the pharmaceutical industry.

Conclusion

Martin Puschmann's contributions to the preparation of gamma globulin highlight his role as an innovator in the pharmaceutical field. His patent reflects a commitment to improving medical treatments, ultimately benefiting patients who rely on gamma globulin therapies.